In cases of acute myeloid leukemia and glioblastoma, the IDH1/2 mutation results in the formation of 2-OH-glutarate, which is a competitive inhibitor of α-KG–dependent processes, especially demethylation of histones (Turcan et al. 2012; Ward et al. 2012). This evidence concerns the gene IDH1 and glioblastoma.